
Jiva.ai
Jiva.ai is the world’s first low code/no code AI platform focusing on multimodality and explainability, that allows users to create, test and deploy AI models all within the Jiva.ai framework.
Jiva.ai is the world’s first low code/no code AI platform focusing on multimodality and explainability, that allows users to create, test and deploy AI models all within the Jiva.ai framework.
Limbic has built an AI therapy assistant to support NHS patients and clinicians throughout treatment – from referral to discharge.
Panakeia offers AI-solutions for faster cancer diagnosis by eliminating the need for multiple lab-based tests.
SiSU Health offers an accessible machine measured health check and digital health platform to help people live a healthier life.
NHS and Councils in Kent and Medway aimed to reach isolated care homes during the pandemic in 2020 and Mark’s team scaled this work to provide digital remote monitoring in 2021.
Mendelian is a digital health company that focuses on building tools to help clinicians detect hard to diagnose diseases. Find out how the DigitalHealth.London Accelerator supported them in building a portfolio of evidence for their flagship product, MendelScan.
Shaun Crowe, Head of Clinical Network Development at NHS England & Improvement (London), is improving clinician, patient and analyst access to integrated data-sets for Diabetes.
Husain Shabeeh, Consultant Cardiologist & Cardiac Electrophysiologist, Croydon University Hospital & King’s College Hospital, is screening for Atrial Fibrillation (AF) in community clinics.
Thomas Coats, Haematology Registrar and Clinical Research Fellow, King’s College Hospital NHS Foundation Trust, is involved in the integration of digitised components to health records in haematology.
Mendelian’s software solution (MendelScan) supports earlier diagnosis of rare diseases.
White Swan is a registered charity which accelerates the path to diagnosis for people with undiagnosed symptoms.
Patients visit their local Medicspot “station,” where they can talk to a doctor via a video link and be remotely examined using the attached diagnostic devices that differentiate it from video-only consultation providers.
MacuSense is a digital cloud solution that streamlines and simplifies clinical decision-making for macular diseases.
Ibex transforms cancer diagnosis by harnessing unique artificial intelligence (AI) and machine learning technology at an unprecedented scale.
i-GP is an online consultation platform to allow patients faster access to primary care for minor illnesses.
An Artificial Intelligence Platform that answers clinical questions by searching through guidelines and articles
Dem Dx’s CE certified AI clinical reasoning platform supports frontline healthcare professionals to diagnose, order investigations and make care recommendations at the first point of contact, before the patient sees a doctor.
Molecular Warehouse is a device that enables a smart phone to automatically upload diagnostic results to encrypted secure servers, to be be shared instantly with doctors.
Cupris is pioneering new ways to diagnose, monitor and treat ear conditions. They have created a product called TYM to turn a smartphone into a clinical-grade otoscope, making it possible to capture, view and share images of the eardrum.
The DigitalHealth.London Generator supported White Swan to pivot their product development roadmap to ensure they are clinically robust, as well as develop a roadmap for, and implement parts of, their evidence generation pathway.
Congenica’s genome analysis software, Sapientia™, is having a very real impact on the lives of patients and their families. Here’s the Tolman’s story.
As part of our continuing Tomorrow’s Patient campaign, DigitalHealth.London profiles the medical research partnership between Moorfields Eye Hospital and Google DeepMind; potentially revolutionising the way professionals carry out eye tests and leading to earlier detection of common eye diseases.
We explore how aparito’s tech solution addresses the needs of its stakeholders simultaneously, thereby overcoming the economic challenges of bringing innovative and affordable medicines to patients with rare disease.